The landscape of diabetes care is evolving with the arrival of skin-applied GLP-1 therapy. These innovative devices offer a possibly more comfortable alternative to injections for individuals managing type 2 diabetes . Such a system deliver a GLP-1 agonist directly through the dermis , bypassing